The algorithm sorts patients into groups, who need grading and don't need grading. The ophthalmologists in the team/system can then focus on diagnosing and treating patients who actually need their time. In this way, RetinaLyze® reduces up to 60% of the manual workload.
RetinaLyze® provides instant results on automated screenings for Diabetic Retinopathy, Age-related Macular Degeneration and Glaucoma. The built-in telemedicine platform also allows operators to communicate with remote graders to receive manual assessments.
Security is important to us. As standard, all communication is encrypted. A middle man won’t be able to view or edit images, results or the client information. RetinaLyze is CE-marked and uses the highest level of encryption available today.
RetinaLyze® is a simple system and has been developed with the aim of being easy to use and easy to learn for clinicians as well as non-clinicians. The system can be easily adapted to fit the needs for a single retail store or clinic, a large chain of optometrists or hospitals as well as a rural screening camp.
We are proud to present RetinaLyze version 3.2.0, which consists of major upgrades to the Glaucoma algorithm and smaller changes to make the system easier to use.
We're proud to announce our partnership with Unica Pharma, who launched the RetinaLyze Glaucoma software in Argentina this weekend. The software was presented by Dr. Jens Thygesen at the IX Biennial Congress of Glaucoma organized by ASAG.
In this article, we're going to be specifically looking at the importance of regular eye checks and what happens if you neglect to visit your local GP, or ophthalmic specialist.
A team of researchers have developed an algorithm, which automatically detects abnormalities and changes linked to the eye disease glaucoma. The new algorithm is now offered as a part of the software, RetinaLyze, which provides instant eye screening results for the 3 most frequent diseases causing blindness glaucoma, macular degeneration and diabetic retinopathy.